Delivery Order SPE2DE21D7010-SPE2D626F46QC
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $31,501.86 delivery order (Contract No. 4570253545) by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 2, 2026. The contract, issued without set-aside designation, is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the RELINE-ONE spinal implant product line....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $34,087.06 delivery order (4570297341) by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, for the supply of RELINE-ONE spinal implant products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 16, 2025. This award was issued under open market...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $12,607.94 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025. This delivery order, with an ultimate completion date of January 5, 2026, covers the procurement of RELINE OPEN IMPLANTS—specialized spinal surgical implants designed to support advanced orthopedic and neurosurgical procedures. The award was...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $47,148.17 for RELINE MAS IMPLANTS on July 22, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating open market competition. The work will be performed in San Diego, California, with an ultimate completion date of August 15, 2025. This delivery order is funded by the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F46QCDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $44,361.93 fixed-price delivery order on January 6, 2026, for RELINE MAS IMPLANTS to support federal healthcare operations. The contract is structured with economic price adjustment provisions and maintains an ultimate completion date of February 27, 2026, with performance conducted at Nuvasive's San Diego facility. The Defense Logistics Agency Medical Supply Chain, operating under the Department of Defense, funded this award without set-aside restrictions, reflecting Nuvasive's successful competition in open market federal procurements. This delivery order is issued against Nuvasive's broader strategic relationship with federal healthcare agencies, including an $8 million Indefinite Delivery/Indefinite Quantity Blanket Purchase Agreement with the Defense Health Agency effective through March 2027. Nuvasive serves as a critical supplier to the Department of Defense, Department of Veterans Affairs, and Defense Health Agency, providing specialized spinal surgery products including fusion devices, interbody implants, bone graft materials, and surgical instruments. The company's contract portfolio demonstrates sustained capability in delivering orthopedic and neurosurgical technologies that support the medical readiness and healthcare delivery missions of military and veteran healthcare systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.4k | 1/5/26 |